Our Pricing

Aciclovir Tablets Side Effects During Pregnancy

Understanding aciclovir tablets side effects pregnancy UK guidance is essential for expectant mothers managing cold sore outbreaks. At Cured Pharmacy, our UK-registered clinical team provides evidence-based advice on aciclovir safety during pregnancy and breastfeeding, with access to both topical and oral treatment options from £4.49.

Is Aciclovir Safe During Pregnancy? UK Clinical Evidence

Aciclovir has been used extensively during pregnancy for over three decades, with reassuring safety data from multiple population studies. A comprehensive Danish registry study of 1,804 pregnancies exposed to aciclovir found no increased risk of major birth defects compared to unexposed pregnancies [1]. The UK Medicines and Healthcare products Regulatory Agency (MHRA) classifies aciclovir as generally safe for use during pregnancy when clinically indicated.

Both oral aciclovir tablets and topical aciclovir cream cross the placenta in limited amounts. However, the systemic absorption from topical formulations like Numark Cold Sore Cream is minimal, making it the preferred first-line option for pregnant women with localised cold sore outbreaks [2]. Oral aciclovir tablets may be prescribed by UK clinicians for severe or recurrent herpes simplex infections during pregnancy, particularly in the third trimester to reduce neonatal transmission risk.

The British Association for Sexual Health and HIV (BASHH) guidelines support aciclovir use throughout all trimesters when the clinical benefit outweighs potential risks. No teratogenic effects have been documented in human studies, though as with all medications during pregnancy, treatment decisions should involve consultation with a UK prescriber [1][3].

Common Aciclovir Side Effects in Pregnant Women

Pregnant women taking aciclovir tablets typically experience similar side effects to non-pregnant users, though pregnancy itself may amplify certain symptoms. The most frequently reported side effects include headache (affecting up to 13% of users), nausea (occurring in approximately 8% of cases), and mild gastrointestinal upset [2]. These symptoms are generally mild and resolve without intervention.

Topical aciclovir formulations produce minimal systemic side effects due to low absorption through intact skin. Local application site reactions such as mild stinging, temporary skin dryness, or slight redness may occur in fewer than 5% of users. Pregnant women with sensitive skin may notice increased reactivity, though this does not indicate harm to the developing baby.

Serious adverse effects from aciclovir during pregnancy are exceptionally rare. Renal function changes, though uncommon, warrant monitoring in women taking high-dose oral aciclovir, particularly those with pre-existing kidney conditions or dehydration from pregnancy-related morning sickness. UK prescribers at Cured Pharmacy assess individual risk factors during the clinical consultation to ensure appropriate treatment selection.

When to Contact Your Healthcare Provider

Seek immediate medical advice if you experience severe headache with visual changes, unusual bruising or bleeding, signs of allergic reaction (facial swelling, difficulty breathing, widespread rash), or significantly reduced urine output while taking aciclovir tablets. These symptoms, though rare, require prompt clinical assessment to distinguish between medication effects and pregnancy complications.

Aciclovir Tablets vs Topical Cream During Pregnancy

The route of aciclovir administration significantly impacts systemic exposure during pregnancy. Topical aciclovir cream applied to cold sores achieves peak plasma concentrations approximately 60 times lower than equivalent oral doses, making it the preferred option for localised herpes labialis in pregnant women [2]. Numark Cold Sore Cream provides effective viral suppression at the application site with negligible maternal or foetal systemic exposure.

Oral aciclovir tablets are reserved for more extensive infections, including genital herpes outbreaks, disseminated herpes simplex, or suppressive therapy in women with frequent recurrences approaching delivery. Standard dosing ranges from 200mg five times daily for active outbreaks to 400mg twice daily for suppressive therapy, with treatment duration determined by clinical response and gestational timing [3].

UK prescribers follow a stepped approach: topical treatment for mild facial cold sores, oral therapy for severe or widespread lesions, and prophylactic regimens for women with documented recurrent genital herpes in late pregnancy. This risk-stratified approach balances maternal comfort, viral suppression, and foetal safety considerations.

Treatment Selection Based on Trimester

First trimester treatment typically favours topical formulations unless severe infection necessitates systemic therapy. Second and third trimester prescribing may incorporate oral aciclovir more liberally, particularly after 36 weeks gestation when suppressive therapy can reduce caesarean section rates in women with recurrent genital herpes. Your UK prescriber will tailor recommendations to your specific clinical presentation and gestational age.

Aciclovir and Breastfeeding: UK Safety Guidance

Aciclovir is considered compatible with breastfeeding by NHS guidelines and the British National Formulary. The medication passes into breast milk in low concentrations, with infant exposure estimated at less than 1% of a typical paediatric dose [4]. This minimal transfer poses negligible risk to nursing infants, allowing mothers to continue breastfeeding while treating cold sore outbreaks.

Topical aciclovir cream presents virtually no risk during lactation, as systemic absorption is minimal and localised application to facial cold sores does not contact breast tissue. Mothers should ensure the cream does not come into direct contact with the infant's mouth during feeding, though accidental exposure to small amounts is not harmful.

Women taking oral aciclovir tablets while breastfeeding should maintain adequate hydration and monitor for any unusual symptoms in their infant, though adverse effects are exceptionally rare. The benefits of treating active herpes infections typically outweigh the minimal theoretical risks associated with breast milk exposure. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) can provide personalised guidance during your clinical consultation.

Alternative Cold Sore Treatments for Pregnant Women

Non-pharmacological management strategies provide valuable adjunctive support during pregnancy. Ice application to prodromal tingling sensations may reduce lesion severity if initiated within the first hour of symptoms. Petroleum jelly or emollient lip balms protect developing cold sores from secondary bacterial infection and reduce discomfort, though they do not possess antiviral properties.

Lysine supplementation has been investigated for herpes simplex prophylaxis, with some studies suggesting 1,000mg daily may reduce outbreak frequency. However, evidence quality remains limited, and pregnant women should consult their midwife or GP before initiating any supplement regimen. Stress reduction techniques, adequate sleep, and sun protection may help prevent cold sore triggers during pregnancy.

For women preferring to avoid all medications during early pregnancy, supportive care alone is a reasonable approach for mild cold sores that do not affect eating or cause significant discomfort. However, untreated herpes infections carry theoretical risks of vertical transmission, particularly during primary outbreaks near delivery, making antiviral therapy medically appropriate in many cases.

When Treatment Cannot Be Delayed

Primary herpes simplex infections during pregnancy, characterised by widespread painful lesions, systemic symptoms, and lack of pre-existing antibodies, require prompt oral antiviral therapy regardless of trimester. These severe presentations carry higher risks of maternal complications and neonatal transmission than recurrent outbreaks, making aciclovir tablets the evidence-based standard of care [3].

How to Use Aciclovir Safely During Pregnancy

Topical aciclovir cream should be applied to cold sores five times daily at approximately four-hour intervals, starting at the first sign of tingling or redness. Wash hands thoroughly before and after application to prevent viral spread to other body sites or individuals. Treatment typically continues for five days, though your UK prescriber may recommend extension if lesions have not fully crusted.

Oral aciclovir tablets require consistent dosing schedules to maintain therapeutic blood levels. Take tablets with a full glass of water and maintain good hydration throughout treatment to support renal clearance. Doses may be taken with or without food, though taking them with meals may reduce gastrointestinal side effects in women experiencing pregnancy-related nausea.

Pregnant women should complete the full prescribed course even if symptoms improve earlier, as premature discontinuation may allow viral replication to resume. Store aciclovir tablets at room temperature away from moisture, and keep topical formulations out of direct sunlight. Never share antiviral medications with others, as individual treatment regimens are tailored to specific clinical circumstances and gestational factors.

Report any new or worsening symptoms to your prescriber promptly, including severe headache, visual disturbances, or signs of dehydration. UK clinical guidelines recommend monitoring renal function in women receiving prolonged high-dose oral aciclovir, particularly those with pre-existing kidney conditions or complicated pregnancies [4].

Scientific References

1. Pasternak, B., & Hviid, A. (2010). Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA, 304(8), 859–866. https://doi.org/10.1001/jama.2010.1206
2. Sheffield, J. S., et al. (2006). Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstetrics & Gynecology, 108(1), 141–148. https://doi.org/10.1097/01.AOG.0000222831.97042.1e
3. British Association for Sexual Health and HIV. (2014). 2014 UK National Guideline on the Management of Genital Herpes. International Journal of STD & AIDS, 26(11), 763–776. https://doi.org/10.1177/0956462415580512
4. Joint Formulary Committee. (2024). British National Formulary (BNF) 87. London: BMJ Group and Pharmaceutical Press. Retrieved from https://bnf.nice.org.uk/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication, particularly during pregnancy or while breastfeeding.